LIGAND PHARMACEUTICALS INC - COM NEW (LGND)

Historical Portfolio Holders from Q1 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q1 2024
16 M
Holdings value Q1 2024
$1.17 B
Value change Q1 2024
+$24.1 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
213
Number of buys Q1 2024
96
Number of sells Q1 2024
-86
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
53220K504
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 16 M $1.17 B +$24.1 M $73.10 214
2023 Q4 15.9 M $1.14 B +$29.9 M $71.42 205
2023 Q3 15.6 M $936 M +$5.47 M $59.92 190
2023 Q2 15.3 M $1.1 B +$33 M $72.10 197
2023 Q1 14.8 M $1.09 B +$25.2 M $73.56 205
2022 Q4 14.5 M $972 M -$14.7 M $66.80 188
2022 Q3 13.9 M $1.2 B -$2.61 M $86.11 191
2022 Q2 14.9 M $1.33 B -$64.9 M $89.22 182
2022 Q1 15.6 M $1.75 B -$90.4 M $112.49 186
2021 Q4 16.2 M $2.51 B -$20.6 M $154.46 210
2021 Q3 16.4 M $2.28 B +$68.6 M $139.32 202
2021 Q2 15.9 M $2.09 B +$57.1 M $131.19 208
2021 Q1 15.4 M $2.35 B -$956 M $152.45 216
2020 Q4 22.4 M $2.22 B -$5.88 M $99.45 227
2020 Q3 22.7 M $2.16 B +$67.3 M $95.32 246
2020 Q2 22 M $2.47 B -$51.4 M $111.85 254
2020 Q1 22.8 M $1.66 B -$15.1 M $72.72 249
2019 Q4 22.4 M $2.34 B -$63.5 M $104.29 251
2019 Q3 23.2 M $2.31 B -$159 M $99.54 267
2019 Q2 24.6 M $2.81 B -$39.3 M $114.15 293
2019 Q1 25.4 M $3.19 B -$112 M $125.71 318
2018 Q4 26.7 M $3.63 B +$256 M $135.70 348
2018 Q3 24.2 M $6.64 B -$318 M $274.49 374
2018 Q2 25.4 M $5.27 B +$238 M $207.17 336
2018 Q1 24.3 M $4 B +$70.5 M $165.16 317
2017 Q4 24.7 M $3.38 B -$25.2 M $136.93 294
2017 Q3 24.6 M $3.35 B -$39.9 M $136.15 285
2017 Q2 24.5 M $2.97 B +$95.4 M $121.40 261
2017 Q1 24.6 M $2.6 B +$242 M $105.84 248
2016 Q4 24.7 M $2.51 B +$4.61 M $101.61 260
2016 Q3 24.3 M $2.48 B +$61.6 M $102.06 257
2016 Q2 24.6 M $2.94 B -$22.7 M $119.27 262
2016 Q1 24.2 M $2.6 B +$161 M $107.09 244
2015 Q4 23.2 M $2.51 B +$43 M $108.42 229
2015 Q3 22.8 M $1.95 B -$32.3 M $85.65 202
2015 Q2 21.3 M $2.15 B -$50.9 M $100.90 212
2015 Q1 22 M $1.69 B +$80.1 M $77.11 181
2014 Q4 21.6 M $1.15 B -$777 K $53.21 177
2014 Q3 21.6 M $1.02 B +$40.5 M $46.99 172
2014 Q2 20.1 M $1.25 B -$48.4 K $62.29 189
2014 Q1 20.8 M $1.4 B +$25.8 M $67.26 184